Menquadfi vial 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F24G7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,183
Award facts
- Contract value 100% obligated
- $83,183.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $83,183.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menquadfi vials (0.5mL), a meningococcal vaccine product. The award was made on January 6, 2026, with an ultimate completion date of January 7, 2026, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031, which serves as the primary procurement vehicle for pharmaceutical products and medical supplies supporting military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor that supplies a comprehensive range of pharmaceutical products, vaccines, medical devices, and healthcare commodities to military and veteran healthcare systems. The company competes on a full and open basis for federal contracts and has demonstrated capability across multiple therapeutic domains. This Menquadfi vaccine order supports the Defense Health Agency and broader military medical supply chain requirements, reflecting the company's role as a primary vendor for essential immunization products needed across Department of Defense healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26F24G7?
SPE2DR26F24G7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F24G7 worth?
The government has obligated $83,183 on SPE2DR26F24G7.
Is contract SPE2DR26F24G7 an order under another contract?
Yes. SPE2DR26F24G7 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F24G7 competed?
The extent of competition for SPE2DR26F24G7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award